Atlas Trials

Relative Bioavailability Study in Healthy Subjects to Evaluate the Pharmacokinetics of HTL0009936 After One Dose of Prototype Formulation

Clinical trial NCT02710188 · COMPLETED

Trial details

NCT number
NCT02710188
Sponsor
Nxera Pharma UK Limited
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Alzheimer's Disease
Start date
2016-02-01
Primary completion
2016-07-01
Enrollment
14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.